Rationale: High flow therapy reduces dyspnea in acute respiratory failure but the underlying mechanisms are not fully elucidated. Objectives: To compare dyspnea, airway occlusion pressure (P0.1) an…
This multisite, single-group, prospective, observational study examines the feasibility and potential impact of genomic newborn screening using dried blood spots in a racially and ethnically…
Join us to read 1 paper per day and stay up-to-date as we cover the spectrum of critical care across 2023
Join us to read 1 paper per day and stay up-to-date as we cover the spectrum of critical care across 2023
Airway diseases are a heterogeneous group of disorders that impact airflow. Recent advances in the field are providing important insights into the management of these…
Rationale: Relatives of patients with familial pulmonary fibrosis (FPF) are at increased risk to develop FPF. Interstitial lung abnormalities (ILAs) are a radiologic biomarker of…
Rationale: Some with interstitial lung abnormalities (ILA) are suspected to have interstitial lung disease (ILD), a subgroup with adverse outcomes. Rates of development and progression…
“.” Annals of the American Thoracic Society, 21(12), pp. 1770–1773 Correspondence and requests for reprints should be addressed to Sujith V. Cherian, M.D., University of…
Idiopathic pulmonary fibrosis (IPF) is an aggressive and, thus far, incurable disease characterized by aberrant fibroblast-mediated extracellular matrix deposition. Our understanding of the disease…
Idiopathic pulmonary fibrosis (IPF) and other forms of fibrotic interstitial lung diseases (ILDs) often follow a relentlessly progressive course, with median survival frequently cited as…
The American Journal of Respiratory and Critical Care Medicine (AJRCCM) is pleased to team up with the New England Journal of Medicine (NEJM) and the…
